What is CIRC China?
What is CIRC China?
The China Insurance Regulatory Commission (CIRC) was an agency of China authorized by the State Council to regulate the Chinese insurance products and services market and maintain legal and stable operations of insurance industry.
Who regulates insurance companies in China?
2 economy strives to recover from the impact of COVID-19. China Banking and Insurance Regulatory Commission (CBIRC) is seeking public advice on the draft and the amendments it makes to a 2010 version of the rules regulating such companies.
What is the Chinese FDA called?
National Medical Products Administration
Focus on China Drugs and medical devices are overseen by the former China Food and Drug Administration (CFDA) now the National Medical Products Administration (NMPA), which reports to the State Administration of Market Regulation (SAMR).
When did CFDA become Nmpa?
1 September 2018
On 1 September 2018, the CFDA (China Federal Drug Administration) was replaced by the NMPA (National Medical Products Association).
What is CDE China?
Per the DRR, NMPA’s Center for Drug Evaluation (CDE) is responsible for the evaluation of drug clinical trial applications, drug marketing authorization applications, supplementary applications, and overseas drug production registration applications.
What is China’s Nmpa?
The National Medical Products Administration (NMPA) is the Chinese agency for regulating drugs and medical devices (formerly the China Food and Drug Administration or CFDA).
How long does Nmpa approval take?
Per the DRR, the DAL, and the NMPA-No50-2018, a clinical trial application will be considered approved after 60 working days if the applicant does not receive a rejection or an inquiry for clarification from the NMPA.
What is China FDA called?
The National Medical Products Administration
The National Medical Products Administration (NMPA) is the Chinese agency for regulating drugs and medical devices (formerly the China Food and Drug Administration or CFDA). The predecessor to the NMPA was initially founded in 1998 to oversee drugs and medical devices.
Does China follow GCP?
In March 2016, the CFDA (China Food and Drug and Administration) and National Health and Family Planning Commission (NHFPC) jointly issued new Good Clinical Practice (GCP) guidelines, which were implemented in June 2016. These guidelines are detailed in CFDA Decree #25.
What is CDE in China?
What is NMPA certification?
The National Medical Products Administration (NMPA) is the Chinese agency for regulating drugs and medical devices (formerly the China Food and Drug Administration or CFDA). The predecessor to the NMPA was initially founded in 1998 to oversee drugs and medical devices.
What is NMPA registration?
What is the China NMPA Registration? NMPA approval was introduced by the Chinese legislation after identifying opportunities in the system in the face of globalization, increasing international competition and in efforts of harmonizing with other international standards.
